Skip to content
Review Open access

Portopulmonary Hypertension: Contemporary Paradigms in Diagnostic and Therapeutic Care

Sep 2026 · Comprehensive Physiology · Vol 16 · 0 citations · 77 references

Abstract

Portopulmonary hypertension (PoPH) is a pulmonary vascular complication of chronic liver disease. The condition is defined as precapillary pulmonary arterial hypertension (PAH) in the context of portal hypertension. Characterized by vasoconstriction and vascular remodeling of pulmonary arterial vessels, PoPH results in increased pulmonary vascular resistance and right ventricular failure. If left untreated, PoPH has poor prognosis indicated by a 5‐year survival of 4%–14%. The mainstay of treatment consists of vasomodulator therapy, although additional clinical trials in this specific patient population are needed. Liver transplantation should be considered only in carefully selected patients. This review summarizes current knowledge on PoPH pathogenesis and provides an update on screening, diagnosis and management.

Read PDF

Similar papers

Review Open access Oct 2026

Portopulmonary hypertension: an integrated approach to diagnosis, risk stratification, and management.

Portopulmonary hypertension (PoPH) is a complex and underrecognized form of pulmonary arterial hypertension arising in the setting of portal hypertension, in which outcomes are driven by the interplay between pulmonary vascular disease and liver dysfunction. Despite advances in hemodynamic definitions and targeted ther...

J. Donate, S. del Prado, Andrés Tenes et al. · 0 citations
Open access Sep 2026

Preliminary study of individualized therapy for ventricular septal defect with severe pulmonary arterial hypertension.

Combining SaO2 with RHC-derived parameters provides a more comprehensive and individualized assessment of disease severity in VSD-PAH than hemodynamics alone and may provide a hypothesis-generating framework for cardiovascular specialists.

Wei-Jie Tang, Jin-Zhou Cai, Shi-Biao Zhang et al. · 0 citations
Open access Oct 2026

Salvage Use of Sotatercept for Potts Shunt in Refractory Pulmonary Hypertension

It is suggested that short‐term perioperative sotatercept can serve as an effective acute rescue therapy to safeguard high‐risk surgical interventions in critical pediatric PAH.

Zhuo-Yuan Xu, Ming-Jie Zhang, Yi-Wei Chen et al. · 0 citations
Review Open access Oct 2026

Pulmonary hypertension: modern approaches to diagnosis and treatment

This review offers a contemporary analysis of the evolving landscape of pulmonary hypertension (PH) diagnosis and management. It synthesizes current evidence on disease mechanisms and therapeutic approaches, with particular emphasis on the pivotal changes introduced by the 2022 ESC/ERS guidelines. Central to this updat...

O. Г. Shust, D. M. Pisaryk, N. С. Anisova et al. · 0 citations
Review Open access Oct 2026

Early outcomes of reversed potts shunt in pediatric pulmonary arterial hypertension

Pediatric pulmonary arterial hypertension carries a poor prognosis. Reversed Potts shunt has been proposed as a bridge from medical therapy to lung transplantation, yet evidence supporting its ability to preserve right ventricular function and improve symptoms in this population remains limited. Pediatric...

X. Lin, J. Yuan, M. Zeng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.